Research & Development



  而且是嫁給不再換老婆,而且還有一半漢家血統的匈奴王子,那個匈奴王子還被一個漢人從小教導……嫁給匈奴王子成為將來的王後,還有什麼不滿意的?   這一聲斷喝嚇得李禹從睡夢中醒來,見道曹襄,也學著雲哲的樣子哭泣了起來。一级a做爰视频免费观看   田氏輝煌過,知道學問的重要性,在山東,已經沒有哪一家的大儒願意招收田氏子弟。伊人久久大香蕉网   與遙遠的一個大國國王屬于同宗,同文,這對大漢朝是有利的。   陪雲瑯接見匈奴使者的李陵,李勇也站了起來,擋在蒙查面前。大香蕉网伊人   搖搖腦袋,勉強讓自己變得清醒些,彎腰拱手不動如山。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo